rs3729856

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_001308093.3(GATA4):​c.1132A>G​(p.Ser378Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.11 in 1,614,072 control chromosomes in the GnomAD database, including 11,064 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.089 ( 848 hom., cov: 33)
Exomes 𝑓: 0.11 ( 10216 hom. )

Consequence

GATA4
NM_001308093.3 missense

Scores

1
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1B:11

Conservation

PhyloP100: 0.363

Publications

53 publications found
Variant links:
Genes affected
GATA4 (HGNC:4173): (GATA binding protein 4) This gene encodes a member of the GATA family of zinc-finger transcription factors. Members of this family recognize the GATA motif which is present in the promoters of many genes. This protein is thought to regulate genes involved in embryogenesis and in myocardial differentiation and function, and is necessary for normal testicular development. Mutations in this gene have been associated with cardiac septal defects. Additionally, alterations in gene expression have been associated with several cancer types. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]
GATA4 Gene-Disease associations (from GenCC):
  • atrial septal defect 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • structural congenital heart disease, multiple types - GATA4
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • testicular anomalies with or without congenital heart disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • metabolic syndrome
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • neonatal diabetes mellitus
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • pancreatic hypoplasia-diabetes-congenital heart disease syndrome
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • permanent neonatal diabetes mellitus
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • transient neonatal diabetes mellitus
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • 46,XY partial gonadal dysgenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial atrial fibrillation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • tetralogy of fallot
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017141104).
BP6
Variant 8-11757066-A-G is Benign according to our data. Variant chr8-11757066-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 44334.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.132 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GATA4NM_001308093.3 linkc.1132A>G p.Ser378Gly missense_variant Exon 6 of 7 ENST00000532059.6 NP_001295022.1 P43694-2B3KUF4B6DU75

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GATA4ENST00000532059.6 linkc.1132A>G p.Ser378Gly missense_variant Exon 6 of 7 1 NM_001308093.3 ENSP00000435712.1 P43694-2

Frequencies

GnomAD3 genomes
AF:
0.0887
AC:
13494
AN:
152210
Hom.:
848
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0211
Gnomad AMI
AF:
0.0956
Gnomad AMR
AF:
0.0530
Gnomad ASJ
AF:
0.184
Gnomad EAS
AF:
0.00135
Gnomad SAS
AF:
0.0488
Gnomad FIN
AF:
0.140
Gnomad MID
AF:
0.104
Gnomad NFE
AF:
0.134
Gnomad OTH
AF:
0.0893
GnomAD2 exomes
AF:
0.0952
AC:
23909
AN:
251156
AF XY:
0.0966
show subpopulations
Gnomad AFR exome
AF:
0.0193
Gnomad AMR exome
AF:
0.0421
Gnomad ASJ exome
AF:
0.173
Gnomad EAS exome
AF:
0.000435
Gnomad FIN exome
AF:
0.147
Gnomad NFE exome
AF:
0.131
Gnomad OTH exome
AF:
0.110
GnomAD4 exome
AF:
0.112
AC:
163346
AN:
1461744
Hom.:
10216
Cov.:
33
AF XY:
0.112
AC XY:
81236
AN XY:
727164
show subpopulations
African (AFR)
AF:
0.0198
AC:
662
AN:
33474
American (AMR)
AF:
0.0459
AC:
2052
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.177
AC:
4621
AN:
26134
East Asian (EAS)
AF:
0.000227
AC:
9
AN:
39700
South Asian (SAS)
AF:
0.0564
AC:
4865
AN:
86254
European-Finnish (FIN)
AF:
0.145
AC:
7762
AN:
53374
Middle Eastern (MID)
AF:
0.138
AC:
793
AN:
5764
European-Non Finnish (NFE)
AF:
0.122
AC:
136088
AN:
1111944
Other (OTH)
AF:
0.108
AC:
6494
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
9141
18283
27424
36566
45707
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4610
9220
13830
18440
23050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0885
AC:
13487
AN:
152328
Hom.:
848
Cov.:
33
AF XY:
0.0868
AC XY:
6465
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.0210
AC:
874
AN:
41576
American (AMR)
AF:
0.0528
AC:
808
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.184
AC:
639
AN:
3470
East Asian (EAS)
AF:
0.00135
AC:
7
AN:
5186
South Asian (SAS)
AF:
0.0487
AC:
235
AN:
4828
European-Finnish (FIN)
AF:
0.140
AC:
1490
AN:
10608
Middle Eastern (MID)
AF:
0.105
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
0.134
AC:
9131
AN:
68030
Other (OTH)
AF:
0.0874
AC:
185
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
650
1299
1949
2598
3248
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
144
288
432
576
720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.116
Hom.:
4719
Bravo
AF:
0.0783
TwinsUK
AF:
0.116
AC:
429
ALSPAC
AF:
0.111
AC:
427
ESP6500AA
AF:
0.0236
AC:
104
ESP6500EA
AF:
0.140
AC:
1204
ExAC
AF:
0.0959
AC:
11648
Asia WGS
AF:
0.0270
AC:
98
AN:
3478
EpiCase
AF:
0.128
EpiControl
AF:
0.125

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:11
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:6
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 13, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Ser377Gly in exon 6 of GATA4: This variant is not expected to have clinical si gnificance because it is not located within the splice consensus sequence. It h as been identified in 14% (927/6596) of European chromosomes, including 67 homoz ygotes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org ; dbSNP rs3729856). -

-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Pathogenic:1Benign:3
Sep 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 30229885, 28541271, 23626780, 28161810, 27064867) -

Nov 13, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Molecular Genetics and Enzymology, National Research Centre
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Neonatal insulin-dependent diabetes mellitus Uncertain:1
-
Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

Potent mutations in GATA4 gene are associated with neonatal diabetes, decreased insulin production due to pancreatic aplasia or hypoplasia. Also associated with isolated cardiac abnormalities in children, like atrial septal defects. However no sufficient evidence is found to ascertain the role of this particular variant rs3729856 yet. -

Atrioventricular septal defect 4 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Jun 23, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.23
CADD
Benign
1.5
DANN
Benign
0.97
DEOGEN2
Benign
0.24
T;T;T;.;T
Eigen
Benign
-0.70
Eigen_PC
Benign
-0.58
FATHMM_MKL
Benign
0.52
D
MetaRNN
Benign
0.0017
T;T;T;T;T
MetaSVM
Benign
-0.40
T
MutationAssessor
Benign
-0.20
.;.;N;.;.
PhyloP100
0.36
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.39
N;N;N;N;.
REVEL
Uncertain
0.29
Sift
Benign
0.42
T;T;T;T;.
Sift4G
Benign
0.47
T;T;T;T;T
Polyphen
0.0
.;.;B;.;.
Vest4
0.081
MPC
0.16
ClinPred
0.0016
T
GERP RS
0.91
Varity_R
0.044
gMVP
0.40
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3729856; hg19: chr8-11614575; COSMIC: COSV58732556; COSMIC: COSV58732556; API